Eva K. Kimby

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Integrated multi-omic profiling reveals two distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Journal: Blood advances
Published: December 09, 2025

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Integrated multiomic profiling reveals 2 distinct splenic marginal zone lymphoma subgroups with prognostic relevance.

Journal: Blood advances
Published: December 09, 2025

Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's Macroglobulinemia.

Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom's Macroglobulinemia.

Journal: Seminars in hematology
Published: April 10, 2025

Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma.

Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma.

Journal: Seminars in hematology
Published: April 06, 2025

Rituximab versus active surveillance in patients with follicular lymphoma.

Rituximab versus active surveillance in patients with follicular lymphoma.

Journal: The Lancet. Haematology
Published: March 29, 2025

Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemia.

Revaccination with pneumococcal conjugate vaccine five years after primary immunization improves immunity in patients with chronic lymphocytic leukemia.

Journal: Haematologica
Published: November 08, 2024

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.

Journal: Blood advances
Published: September 17, 2024

Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study.

Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population-based study.

Journal: EJHaem
Published: February 24, 2024

Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.

Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.

Journal: Blood cancer journal
Published: January 19, 2024

Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.

Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.

Journal: Leukemia & lymphoma
Published: September 08, 2023

Personalised therapy in follicular lymphoma - is the dial turning?

Personalised therapy in follicular lymphoma - is the dial turning?

Journal: Hematological oncology
Published: April 06, 2023

Career development: A balance of opportunities and choices.

Career development: A balance of opportunities and choices.

Journal: Hematological oncology
Published: April 05, 2023
Showing 1-12 of 108

Last Updated: 09/26/2026